Other Species / Isoforms
  IFNGR1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K115-ub
QKESAYAkSEEFAVC
0 2
IFNGR1 (human) QKESAYAkSEEFAVC K115-ub
IFNGR1 (mouse) QKESDYARSKEFLMC R121
IFNGR1 (rat) QRESAYAQSEEFIMC Q112
S262-p
LLLFLVLsLVFICFY
0 1
IFNGR1 (human) LLLFLVLsLVFICFY S262-p
IFNGR1 (mouse) LTVFTVVILVFAYWY I270
IFNGR1 (rat) LLFLTIVVPALVCCY V257
K279-ub
KINPLKEkSIILPkS
0 4
IFNGR1 (human) KINPLKEkSIILPkS K279-ub
IFNGR1 (mouse) KKNSFKRKSIMLPkS K286
IFNGR1 (rat) KKNPFKRKSIMLPKS K273
K285-ub
EkSIILPkSLIsVVR
0 24
IFNGR1 (human) EkSIILPkSLIsVVR K285-ub
IFNGR1 (mouse) RKSIMLPkSLLsVVk K292-ub
IFNGR1 (rat) RKSIMLPKSLLSVVK K279
S289-p
ILPkSLIsVVRsAtL
0 7
IFNGR1 (human) ILPkSLIsVVRsAtL S289-p
IFNGR1 (mouse) MLPkSLLsVVksAtL S296-p
IFNGR1 (rat) MLPKSLLSVVKNATS S283
R292
kSLIsVVRsAtLEtk
0 2
IFNGR1 (human) kSLIsVVRsAtLEtk R292
IFNGR1 (mouse) kSLLsVVksAtLEtK K299-ub
IFNGR1 (rat) KSLLSVVKNATSETK K286
S293-p
SLIsVVRsAtLEtkP
0 24
IFNGR1 (human) SLIsVVRsAtLEtkP S293-p
IFNGR1 (mouse) SLLsVVksAtLEtKP S300-p
IFNGR1 (rat) SLLSVVKNATSETKP N287
T295-p
IsVVRsAtLEtkPEs
Upstream
0 66
Treatment
  • gefitinib
  • wortmannin
IFNGR1 (human) IsVVRsAtLEtkPEs T295-p
IFNGR1 (mouse) LsVVksAtLEtKPES T302-p
IFNGR1 (rat) LSVVKNATSETKPES T289
T298-p
VRsAtLEtkPEsKyV
0 4
IFNGR1 (human) VRsAtLEtkPEsKyV T298-p
IFNGR1 (mouse) VksAtLEtKPESKYS T305-p
IFNGR1 (rat) VKNATSETKPESKYS T292
K299-ub
RsAtLEtkPEsKyVs
0 5
IFNGR1 (human) RsAtLEtkPEsKyVs K299-ub
IFNGR1 (mouse) ksAtLEtKPESKYSL K306
IFNGR1 (rat) KNATSETKPESKYSL K293
S302-p
tLEtkPEsKyVsLIt
0 1
IFNGR1 (human) tLEtkPEsKyVsLIt S302-p
IFNGR1 (mouse) tLEtKPESKYSLVTP S309
IFNGR1 (rat) TSETKPESKYSLVTS S296
Y304-p
EtkPEsKyVsLItsy
0 31
IFNGR1 (human) EtkPEsKyVsLItsy Y304-p
IFNGR1 (mouse) EtKPESKYSLVTPHQ Y311
IFNGR1 (rat) ETKPESKYSLVTSCQ Y298
S306-p
kPEsKyVsLItsyQP
0 1
IFNGR1 (human) kPEsKyVsLItsyQP S306-p
IFNGR1 (mouse) tKPESKYSLVTPHQP S312
IFNGR1 (rat) TKPESKYSLVTSCQP S299
T309-p
sKyVsLItsyQPFsL
0 1
IFNGR1 (human) sKyVsLItsyQPFsL T309-p
IFNGR1 (mouse) ESKYSLVTPHQPAVL T315
IFNGR1 (rat) ESKYSLVTSCQPAVL T302
S310-p
KyVsLItsyQPFsLE
0 2
IFNGR1 (human) KyVsLItsyQPFsLE S310-p
IFNGR1 (mouse) SKYSLVTPHQPAVLE P316
IFNGR1 (rat) SKYSLVTSCQPAVLE S303
Y311-p
yVsLItsyQPFsLEK
0 47
IFNGR1 (human) yVsLItsyQPFsLEK Y311-p
IFNGR1 (mouse) KYSLVTPHQPAVLES H317
IFNGR1 (rat) KYSLVTSCQPAVLEN C304
S315-p
ItsyQPFsLEKEVVC
0 1
IFNGR1 (human) ItsyQPFsLEKEVVC S315-p
IFNGR1 (mouse) VTPHQPAVLESETVI V321
IFNGR1 (rat) VTSCQPAVLENETVI V308
S327-p
VVCEEPLsPATVPGM
Upstream
0 7
Treatment
  • selumetinib
  • vemurafenib
IFNGR1 (human) VVCEEPLsPATVPGM S327-p
IFNGR1 (mouse) VICEEPLSTVTAPDS S334
IFNGR1 (rat) VICEEHLSTVTTPDS S321
N361
EVVTTEENIPDVVPG
0 1
IFNGR1 (human) EVVTTEENIPDVVPG N361
IFNGR1 (mouse) KALEAGGsTSAMtPD S362-p
IFNGR1 (rat) VATVAEGNTSPETTD N349
V366
EENIPDVVPGSHLTP
0 2
IFNGR1 (human) EENIPDVVPGSHLTP V366
IFNGR1 (mouse) GGsTSAMtPDsPPtP T367-p
IFNGR1 (rat) EGNTSPETTDSPPTP T354
S369
IPDVVPGSHLTPIER
0 10
IFNGR1 (human) IPDVVPGSHLTPIER S369
IFNGR1 (mouse) TSAMtPDsPPtPtQR S370-p
IFNGR1 (rat) TSPETTDSPPTPVQS S357
T372
VVPGSHLTPIEREsS
0 10
IFNGR1 (human) VVPGSHLTPIEREsS T372
IFNGR1 (mouse) MtPDsPPtPtQRRsF T373-p
IFNGR1 (rat) ETTDSPPTPVQSGHF T360
I374
PGSHLTPIEREsSSP
0 2
IFNGR1 (human) PGSHLTPIEREsSSP I374
IFNGR1 (mouse) PDsPPtPtQRRsFsL T375-p
IFNGR1 (rat) TDSPPTPVQSGHFSL V362
S378-p
LTPIEREsSSPLsSN
0 10
IFNGR1 (human) LTPIEREsSSPLsSN S378-p
IFNGR1 (mouse) PtPtQRRsFsLLSSN S379-p
IFNGR1 (rat) PTPVQSGHFSLSSSN H366
S380
PIEREsSSPLsSNQs
0 2
IFNGR1 (human) PIEREsSSPLsSNQs S380
IFNGR1 (mouse) PtQRRsFsLLSSNQS S381-p
IFNGR1 (rat) PVQSGHFSLSSSNQS S368
S383-p
REsSSPLsSNQsEPG
0 1
IFNGR1 (human) REsSSPLsSNQsEPG S383-p
IFNGR1 (mouse) RRsFsLLSSNQSGPC S384
IFNGR1 (rat) SGHFSLSSSNQSGSC S371
S387-p
SPLsSNQsEPGsIAL
0 1
IFNGR1 (human) SPLsSNQsEPGsIAL S387-p
IFNGR1 (mouse) sLLSSNQSGPCSLTA S388
IFNGR1 (rat) SLSSSNQSGSCSLTT S375
S391-p
SNQsEPGsIALNsyH
0 1
IFNGR1 (human) SNQsEPGsIALNsyH S391-p
IFNGR1 (mouse) SNQSGPCSLTAYHsR S392
IFNGR1 (rat) SNQSGSCSLTTYHSR S379
S396-p
PGsIALNsyHsRNCs
0 1
IFNGR1 (human) PGsIALNsyHsRNCs S396-p
IFNGR1 (mouse) SGPCSLTAYHsRNGs A395
IFNGR1 (rat) SGSCSLTTYHSRDGS T382
Y397-p
GsIALNsyHsRNCsE
0 12
IFNGR1 (human) GsIALNsyHsRNCsE Y397-p
IFNGR1 (mouse) GPCSLTAYHsRNGsD Y396
IFNGR1 (rat) GSCSLTTYHSRDGSD Y383
S399-p
IALNsyHsRNCsESD
0 7
IFNGR1 (human) IALNsyHsRNCsESD S399-p
IFNGR1 (mouse) CSLTAYHsRNGsDsG S398-p
IFNGR1 (rat) CSLTTYHSRDGSDSG S385
S403-p
syHsRNCsESDHSRN
0 3
IFNGR1 (human) syHsRNCsESDHSRN S403-p
IFNGR1 (mouse) AYHsRNGsDsGLVGs S402-p
IFNGR1 (rat) TYHSRDGSDSGLVGT S389
S416
RNGFDTDSSCLESHS
0 1
IFNGR1 (human) RNGFDTDSSCLESHS S416
IFNGR1 (mouse) HsRNGsDsGLVGsGS S404-p
IFNGR1 (rat) HSRDGSDSGLVGTGS S391
S421
TDSSCLESHSSLSDS
0 1
IFNGR1 (human) TDSSCLESHSSLSDS S421
IFNGR1 (mouse) sDsGLVGsGSsISDL S409-p
IFNGR1 (rat) SDSGLVGTGSSISDS T396
S424
SCLESHSSLSDSEFP
0 1
IFNGR1 (human) SCLESHSSLSDSEFP S424
IFNGR1 (mouse) GLVGsGSsISDLESL S412-p
IFNGR1 (rat) GLVGTGSSISDSDFL S399
K450-ub
QELITVIkAPTsFGy
0 1
IFNGR1 (human) QELITVIkAPTsFGy K450-ub
IFNGR1 (mouse) under review -
IFNGR1 (rat) under review -
S454-p
TVIkAPTsFGyDkPH
0 1
IFNGR1 (human) TVIkAPTsFGyDkPH S454-p
IFNGR1 (mouse) PVRKAPMASGyDKPH A442
IFNGR1 (rat) PVRKALTFSGYDKPH F429
Y457-p
kAPTsFGyDkPHVLV
Upstream
Downstream
4 36
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
  • transcription, altered
Treatment
  • herbimycin_A
  • IFN-gamma
IFNGR1 (human) kAPTsFGyDkPHVLV Y457-p
IFNGR1 (mouse) KAPMASGyDKPHMLV Y445-p
IFNGR1 (rat) KALTFSGYDKPHVLV Y432
K459-ub
PTsFGyDkPHVLVDL
0 1
IFNGR1 (human) PTsFGyDkPHVLVDL K459-ub
IFNGR1 (mouse) PMASGyDKPHMLVDV K447
IFNGR1 (rat) LTFSGYDKPHVLVDV K434
Y479-p
GKESLIGyRPTEDSK
1 1
IFNGR1 (human) GKESLIGyRPTEDSK Y479-p
IFNGR1 (mouse) GKESLMGyRLTGEAQ Y467-p
IFNGR1 (rat) GKESLIGYRLTGDTQ Y454